GWP
XBI icon

Gateway Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gateway Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
9,716
-2,222
-19% -$300K 0.09% 230
2026
Q1 		$1.52M Buy
+11,938
New +$1.49M 0.06% 302

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Gateway Wealth Partners's XBI Position: Q2 2026 in Review

Gateway Wealth Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q2 2026, selling an estimated $300K and leaving 9,716 shares worth $1.54M. The position accounts for 0.09% of the portfolio, ranked #230.

Gateway Wealth Partners first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Gateway Wealth Partners held 9,716 shares of State Street SPDR S&P Biotech ETF worth $1.54M as of Q2 2026.
  • Gateway Wealth Partners sold 2,222 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $300K.
  • State Street SPDR S&P Biotech ETF made up 0.09% of Gateway Wealth Partners's portfolio in Q2 2026, its #230 holding.
  • Gateway Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.